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Bax expression has prognostic significance that is
enhanced when combined with AgNOR counts in glottic
carcinomas
X Xiel, OPF Clausen2, P De Angelis2 and M Boysen'
Departments of 'Otolaryngoy and 2Pathology, The National Hospital, Rikshospialet, University of Oslo. Oslo. Norway
Summary Using nucleolar organizer regions (NORs) as a proliferative marker and Bax expression as a marker for apoptosis, we have
studied the individual and combined prognostic significance of these markers. Successive sections ofdiagnostic, formalin-fixed and paraffin-
embedded specimens from 69 patients with T1-4 tumours were stained with a rabbit anti-human Bax polyclonal antibody and silver nitrate for
visualization of NORs (AgNORs). After classification forstaining intensity and the percentage of Bax expression, a final score resulting in four
classes of increasing Bax expression was obtained. AgNOR counts were expressed as mean counts (mAgNOR) and the percentage of
tumour nuclei with more than one AgNOR (pAgNOR>1). Both AgNOR parameters were grouped in three classes with increasing values. Low
Bax scores correlated significantly with poor prognosis (P=0.0106). For mAgNOR and pAgNOR>1, high values correlated with poor
prognosis (P= 0.0185 and P = 0.0003 respectively). A combined parameter, forwhich the Bax score was subtracted from the AgNOR scores,
appeared to be statistically stronger than the individual parameters (P < 0.0001). Both Bax expression and AgNOR scores, and in particular
the combination of these parameters, appear to be strong prognostic markers in glottic squamous cell carcinomas.
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The growth rate of a tumour depends on both the proliferation and
loss of tumour cells (Reed. 1994). Loss of cells can occur by
necrosis or apoptosis. Necrosis is a result ofenvironmental factors.
such as loss of blood supply. whereas apoptosis represents
programmed cell death triggered by intrinsic cellular mechanisms.
Apoptosis occurs in virtually all tissues that have the capacity for
self-renewal. including malignant tumours (Searle et al. 1973:
Wyllie. 1985).
Recently. a family of genes whose encoded proteins share amino
acid sequence homology with Bcl-2 have been identified. This
family of proteins include Bcl-2. Bcl-x and Mcl-l. which act as
blockers ofapoptosis. whereas others such as Bax and Bak appear to
promote apoptosis (Oltvai. 1993: Boise et al. 1995). The biological
mechanisms by which the Bcl-2 gene family regulate apoptosis
remain uncertain. The Bax protein seems. however. to act as a
central regulator within this multigene family. Several studies have
demonstrated that increased Bax expression is associated with
increased radio- and chemosensitivity to induction of apoptosis
(Bargou et al. 1996: Chresta et al. 1996: Kitadaetal. 1996: Sakakura
et al. 1996: Stoetzer et al. 1996: Thomas et al. 1996: Wagener et al.
1996). Information regarding the prognostic significance of Bax in
human tumours is scarce. It has, however, been shown that reduced
Bax expression correlates with tumour progression and shortened
sunrival in breast adenocarcinomas (Krajewski et al. 1995).
Moreover. it has been demonstrated that the bcl-2/bax mRNA
expression ratio represents a prognostic marker in low-grade urinary
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bladder cancer (Gazzanica et al. 1996). To our knowledge. the
possible significance ofBax expression in head and neck squamous
cell carcinomas has not been studied.
Nucleolar organizer regions (NORs) are loops of ribosomal
DNA involved in RNA transcription and protein synthesis. NORs
can be visualized as black dots by a simple silver staining tech-
nique (AgNOR) (Ploton et al. 1986). AgNOR staining. which is
one ofseveral biological proliferative markers currently used, is as
a rule expressed as mean counts (mAgNOR). Several studies on
malignant tumours. including head and neck squamous cell carci-
nomas. have shown that the mAgNOR counts were higher in
tumours with poor prognosis than in those with good prognosis
(Contractor et al. 1989: Ruschoff et al. 1990: Ofner et al. 1990:
Kolar et al. 1992: Delahunt et al. 1993: Piffko et al. 1997). With
increasing mAgNOR counts. the percentage of nuclei with more
than one AgNOR (pAgNOR>lI) increases. Recently. we showed
that this new AgNOR parameter was a strong prognostic marker in
glottic and oral squamous cell carcinomas (Xie et al. 1997a and b).
In this study. we have investigated the expression ofBax and its
significance regarding treatment failures in glottic squamous cell
carcinomas. These results were compared with those obtained by
AgNOR counts. i.e. mAgNOR and pAgNOR>l. We also tested
whether the combination of the proliferative- and apoptosis-
related parameters could enhance the predictive power regarding
the disease-free period.
MATERIAL AND METHODS
Patients
From a total of approximately 300 patients with glottic carci-
nomas. treated at our department between 1984 and 1990. 33
patients in whom the treatment failed. i.e. residual disease
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following completion of treatment or recurrence, and 36 patients
with no evidence of recurrence were selected for this study. All
relevant clinical findings, treatment and follow-up have been
recordedprospectively. None ofthepatients were lost tofollow-up
and, fornon-failures, the period ofobservation ranged from 1.8 to
11.8 years (mean 6.1 years). Only two of the non-failures had a
period of observation shorter than 3 years. There were 20 TI,
24 T2, 11 T3 and 14 T4 tumours, all NO (UICC classification
of 1987), with the failures equally distributed according to the
T classes. The mean age was 62 years (range 35-78 years) with
two female and 67 male patients.
Patients with Ti-T3 carcinomas were treated with radiotherapy
alone as primary reautent, whereas T4 tumours received
combined tratment with preoperative radiotherapy and surgery.
When patients with T4 tumos on admittance had stridorous
respiration, which necessitated securing of the airways, laryngec-
tomy was performed before radiotherapy. Treatment with radio-
therapy alone for T4 tumours was applied if the patients refused
surgery or when medical containdications prevented such treat-
ment The radiation dose delivered to the primary tumour ranged
from 60 to 70 Gy (2 Gy per day, 5 days per week). Patients with
T3 and T4 tumours also received elective radiotherapy ofthe neck
(50 Gy). Fifty-nine patients (including four T4 tunours) received
radiotherapy alone as primary treatent.
Histth and immunohistochemical staining
Successive 4-un sections were cut from the tissue blocks and
mounted on gelatin-coated slides. One section was stained with
haematoxylin and eosm to verify the initial routine histopatho-
logical diagnosis.
Bax immunostaining and evaluation
In brief, the Bax immunostaining was performed as follows.
Fomalin-fixed, paraffin-embedded tissue sections were deparaf-
finized by two washes in xylene for 5 min each and then dehy-
drated in absolute ethanol. The sections were incubated in 3%
(v/v) hydrogen peroxide in methanol (45 s) to block endogenous
peroxidase, followed by incubation with 95% and 70% ethanol
(15 s each), distilled water (1 min) and phosphate-buffered saline
(PBS) (5 min). They were then heated in a pressure cooker for
5 min in 10 mm citric acid buffer (pH 6.0), followed by rinsing in
lukewarm tap water. The sections were then placed in TBS (Tris-
buffered saline, pH 7.8) for 5 min and then blocked in TNK buffer
(100 mM Tris, pH 7.6-7.8,550 mm sodiumchloride, 10 mM potas-
sium chloride), which contained 2% (w/v) bovine serum albumin
(BSA), 0.1% Triton X-100 and 1% normal goat serum. A rabbit
anti-human Bax polyclonal antibody (Santa Cruz Biotechnology,
CA, USA; 1:20 dilution of 100gg ml-' stock made up in TNK
buffer) was added and the sections incubated overnight in a
humidified chamber placed in the refrigerator. They were then
washed once with PBS and incubated for 1 h at room temperature
in a humidified chamber with biotinylated goat anti-rabbit anti-
body (1:500) made up in TNK buffer, followed by washing with
PBS. They were then incubated for 30 min at room temperature
with streptavidin horseradish peroxidase (1:20) made up in TNK
buffer, then in development solution containing 0.06% diamino-
benzidine (DAB) and 0.1% (v/v) hydrogen peroxide made up in
TNK buffer (without goat serum, BSA and Tnton XI00) and
finally counterstained with haematoxylin and mounted
All sections were reviewed in conjunction by two ofthe authors
(XX and OPFC) and classified according to estimates of percent-
ages of cells stained and staining intensity. The percentages of
positive tumour cells were graded into four classes: class 0, 0%;
class 1, 1-30%; class 2, 31-70%; and class 3, 70-100%. The
staining intensity was classified into five classes: negative, 0;
weak. 0.5; moderate, 1; intense, 1.5; and very intense, 2. The
intensity of the imunostaiing sometimes appeared heteroge-
neous. Having considered the whole tumourarea, we classified the
degree of Bax expression according to the most prevailing inten-
sity. Muscular tissue and/or normal epithelium, which was present
in nearly all sections, served as intemal control for the staining
intensity and was classified as 1. Occasional disagreement
regarding the classification was discussed and a consensus
reached. The estimates both for the percentage ofcells stained and
for the intensity were then added and grouped as follows: 0-1.5,
score 0; 2.0-3.0, score 1; 3.5-4.0, score 2; and exceeding 4.5,
score 3. A Bax score of 0 was found in ten cases, score 1 in 14
cases, score 2 in 29 cases and score 3 in 16 cases.
AgNOR staining and evaluation
The staining and counting were performed according to the
methodpreviously described (Ploton et al, 1986; Xie et al, 1997a).
In brief, the sections were dewaxed and rehydrated. The silver
reaction was performed with a freshly prepared solution of two
parts of 50% silver nitrate in distilled, deionized water and one
part of2% gelatin in 1% formic acid for 45 min at room tempera-
ture. After thorough washing, the sections were placed in 5%
sodium thiosulphate, dehydrated and mounted. The sections were
stored in a dark cool place.
In each section, five fields were evaluated using a 100x oil
immersion lens. The first field was subjectively selected, and the
subsequent fields were systematically chosen roughlyproportional
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to the overall size of the tumour area. By careful focusing. all
clearly distinguishable black dots within the nuclei were identi-
fied. Black dots within nucleoli or aggregated clusters were treated
as one AgNOR. For mAgNOR counts. the number of AgNORs
were counted in 20 nuclei in each of five fields and a mean was
obtained. For the pAgNOR count. the numbers of nuclei with one
and more than one AgNOR were counted, and the percentage of
nuclei with more than one AgNOR (pAgNOR>l) was calculated.
The AgNOR scores were derived from counts presented in a
previous study (Xie et al. 1997a). In that study. we showed that
pAgNOR>l counts exceeding 85% correlated with a poor prog-
nosis and those below this value with a good prognosis. In order to
give AgNOR counts and Bax expression approximately the same
range and weight. pAgNOR>l counts were classified as follows:
<80%. score 1: 81-90%. score 2: and >91%. score 3. The mean
mAg,NOR count was 4.3. Similarlv. the mAgNOR counts were
classified in three classes: .3.0. score 1: 3.1-5.5. score 2: and .5.5.
score 3. A pAgNOR>I score of 1 was found in 25 cases. score 2 in
18 cases. score 3 in 26 cases. For mAgNOR. the number of cases
was 18. 27 and 24 for score 1. 2 and 3 respectively.
For both parameters. evaluated areas with necrosis. pronounced
inflammation. artificial damage and marked keratinization were
avoided. The assessments were performed without knowledge
concerning the clinical outcome.
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Figure 2 pAgNOR>1 score in relabon to non-failures and failures in 69
patients with glotfic squamous cell carcinoma (P= 0.0001)
Statistics
The data were stored and analvsed bv means ofSAS 6.10 software
(SAS Institute. Carv. NC. USA). The chi-squared test was used
for comparison of treatment failures/non-failures and Bax and
AgNOR scores. Having decided cut-off levels for clinical parame-
ters. Bax expression and AgNOR scores. the log-rank test was
used to test the prognostic significance of each parameter in rela-
tion to the disease-free period. A case was censored if death
resulted from unrelated diseases or ifthe patient was alisve with no
evidence of the index tumour at the last follow-up consultation.
Kaplan-Meier plots were used to illustrate the effect of selected
variables and combinations ofvariables on the disease-free period.
P-values <0.05 were considered to be statistically significant.
RESULTS
Five cases (7%7c) were Bax negative. In 36 cases (52%-) exhibited.
more than 80%7 of the tumour area showed a faint to very intense
staining. The remaining 28 cases (41%) stained in a patchy w-ay
Strong Bax immunostaining was usually seen in well-differentiated
or keratinized tumour cells. whereas undifferentiated tumour cells
were often negative or showed a faint staining. Occasional areas
with carcinoma in situ all exhibited strong Bax immunostaining.
No correlations were found between Bax expression and
T-classification. but. as shown in Figure 1. the Bax expression was
significantly lower in patients in whom the treatment failed than in
those in whom the treatment was successful (P = 0.002). Both for
pAgNOR>>l and mAgNOR counts. the scores were lower for TI-2
compared with T3-4 tumours (P = 0.001). pAgNOR>l (Figure 2)
and mAgNOR scores were lower in non-failures than in failures
(P = 0.001 and 0.017 respectively).
Loo-rank analysis showed that the Bax expression and both
pAgNOR>l and mAgNOR counts were statistically significant in
relation to the length of the disease-free period (Table 1). Because
of the particular selection used in this material. no significant
Table 1 Number of treatment failures and log-rank anals conceming the
disease-free period for Bax expression and AgNOR counts in 69 patents
with glottic squamous cell carcinoma
No. of No. of
Group meanrs cases in failures in Log-rank
Parameters cut-off bvels each group each group P-value
Bax score .1 vs >1 28/41 19/14 0.0106
pAgNOR>1 score 1 vs >2 25/44 4/29 0.0003
mAgNOR score 1 vs >2 18/51 4/29 0.0185
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Figure 3 Disease-free period (Kapan-Meier plot) in relation to scores for
Bax expression in 69 cases of glottic squamous cell caranoma (P= 0.0106).
0, Bax score .1; *, Bax score >1
correlation could be expected regarding T-classification. Figure 3
presents the Kaplan-Meier plots for the Bax expression in relation
to the disease-free period (P= 0.0106) and Figure 4 the corre-
sponding relationship regarding pAgNOR>I (P = 0.0003).
A scatter diagram (Figure 5) combining Bax and pAgNOR>l
shows that there was no association between these two parameters.
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Figure 4 Disease-free penod (Kaplan-Mer piot) in relation to pAgNOR>1
scores in 69 cases of giottic squamous cell carcinoma (P= 0.0003). 0,
pAgNOR>1 score <1, M, pAgNOR>1 score >1
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Figure 6 Disease-free period (Kaplan-leer plot) in relation to a parameter
combining the scores for Bax expression and pAgNOR>1 (pAgNOR>1-Bax
expression) in 69 cases of giottic squamous cell carcinoma (P= 0.0001) *0.
pAgNOR>1-Bax expression S0; *, pAgNOR>1-Bax expression >0
discnrminating failures and non-failures (see Figures 1 and 2)
urged us to test the possible significance of combining the two
parameters. When the Bax score was subtracted from the
pAgNOR>l score. we found that this combined parameter
appeared to be a statistically stronger prognostic factor than the
respective single parameters. A similar combination of mAgNOR
and Bax expression also emerged as a strong prognostic predictor
(Table 2). Figure 6 presents the Kaplan-Meier plot regarding the
disease-free period for the combined pAgNOR>l score-Bax score
(P < 0.0001). This parameter predicted all but four of the 33 fail-
ures and 34 of the 36 non-failures. Further improvement in the
discrimination between prognostic favourable and poor cases may
be obtained by a posterion classification for Bax expression and
AgNOR values, but this has not been tested.
0 1 2
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Figure 5 Scatter diagram for Bax and pAgNOR>1 scores. 0, Non-failures;
failures
Table 2 Number of treatment failures and log-rank analysis regarding the
disase-free penod for the combination of scores for AgNOR parameters and
Bax expression in 69 patients with gloftic squamous cell carcinoma.
No. of No.of
Group means/ cases in failures in Log-rank
Parameters cut-off levels each group each group P-value
pAgNOR>1 score
-Bax score <Ovs >0 38/31 4/29 <0.0001
mAgNOR score
-Bax score cO vs >0 38/31 7/26 <0.0001
In relation to the prognosis. a complex association between the
two parameters was found. Low scores for pAgNOR>l and high
scores for Bax expression correlated with a favourable prognosis.
whereas low scores for Bax expression and high scores for
pAgNOR>l was associated with a poor prognosis. The inverse
relationship between the Bax expression and pAgNOR>1 in
DISCUSSION
In this study. we show that low, Bax expression correlated with
poor prognosis and high expression with a favourable prognosis in
glottic squamous cell carcinomas. These findings are in agreement
with the results of recent studies on patients treated with
chemotherapy for metastatic breast adenocarcinomas (Krajewski
et al. 1995) and with the prognosis in low-grade urinary bladder
cancer (Gazzaniga et al. 1996). How the Bax protein promotes
apoptosis is uncertain, but several in vivo and in vitro studies have
shown that Bax protein expression correlates with response to
radio- and chemotherapy (Krajewski et al. 1995; Bargou et al.
1996: Chresta et al, 1996: Kitada et al, 1996: Sakakura et al. 1996:
Stoetzer et al. 1996: Thomas et al. 1996: Wagener et al. 1996). As
the majority of patients included in this series received radio-
therapy alone as primary treatment. high Bax expression may be
interpreted as an indicator ofresponse to radiotherapy.
Most of the previous studies on squamous cell carcinomas of the
head and neck have used the mAgNOR counting method (Pich et al.
1991: Sano et al. 1991: Bockmil et al. 1992: Hirsch et al. 1992).
These studies show variation in overall mAgNOR count ranging
from 4.3 to 15.1 (Bockmdl et al. 1992: Hirsch et al. 1992).
Methodological problems, such as staining technique. variation in
section thickness and the unambiguous identification ofall AgNORs.
may explain the diversity in mean AgNOR counts. The other
counting method used in this study is a modification of the method
introduced by Mourad and co-workers (Mourad et al. 1992).
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Contrary to their study. we have in our previous studies (Xie et al.
1997a and b) chosen to focus on the counting of nuclei with only a
few AgNORs and evaluated the prognostic significance of the
percentage of nuclei with more than one, more than two. more than
three, and four and more AgNORs (pAgNOR>l. pAgNOR>2.
pAgNOR>3 and pAgNOR_4 respectively). Of these. pAgNOR>l
emerged as the statistically strongest pAgNOR parameter. This para-
meter also appeared to be considerably more potent than mAgNOR
counts (Xie et al. 1997a and b). The pAgNOR>l parameter has the
advantage that the time-consuming and tedious identification of all
AgNORs is avoided- When nuclei only show one AgNOR dot, this is
usually large and easily identifiable. The pAgNOR>l count is most
probably less sensitive to variation in section thickness and variations
in staining technique than mean counts. Moreover this paramneter
shows an excellent reproducibility (Xie et al. 1997a and b).
The biological significance ofnuclearorganizerregions (NORs)
remains unknown. Several studies have, however. demonstrated a
relationship between AgNOR quantity and cell proliferation
(Mirre and Knibiehler. 1982: Carbajo et al. 1993: Ruschoff et al.
1994). Usually. resting cells have only one AgNOR (Mirre and
Knibiehler. 1982: Carbajo et al. 1993). The number of AgNORs
increase from early G,-phase to late S-/G,-phases (Carbajo et al.
1993: Ruschoff et al. 1994). Further evidence for the idea that
AgNOR counts represent a marker for proliferative activity has
been presented in a study using double staining with Ki67 and
AgNOR (Mourad et al. 1994). While Ki67-negative cells only had
one to three. the Ki67-positive cells had 2-12 AgNORs. Similarly.
both pAgNOR and mAgNOR counts have been found to correlate
with other proliferative markers. such as the S-phase fraction. the
BrdU-labelling index and Ki67 labelling index (Mourad et al,
1992. 1993. 1994). These findings suggest that pAgNOR>l
reflects some aspects of the tumour proliferative activity. as does
the mean AgNOR score. Because of the simplicity of the
pAgNOR>l counting method and a higher degree of repro-
ducibility. pAgNOR>l rather than mAgNOR is. in our view. the
preferred AgNOR parameter (Xie et al. 1997a and b).
Despite the fact that T-stage in glottic carcinomas correlates
well with prognosis (Vermund et al. 1990). we found no associa-
tion between Bax expression and T-stage. The reason for this
somewhat contradictory finding may be that the Bax expression
was not astatistically strong parameter and that the two parameters
pick out different groups of patients. Neither did we find any
correlation between Bax expression and pAgNOR>l or mAgNOR
scores. This is consistent with the results of a study on breast
adenocarcinomas in which the S-phase fraction was used as a para-
meter reflecting the proliferative activity (Krajewski et al. 1995).
When we combined Bax expression and pAgNOR>I for treatment
response (see Figures 5 and 6). a strong cooperative relationship
between these two variables emerged that predicted 29 of the 33
failures and 34 ofthe 36 non-failures.
Our investigation confirms that AgNOR enumeration is a prog-
nostic marker and further suggests that Bax expression is a poten-
tial prognostic marker. Whereas Bax expression may reflect the
response to radiation-induced apoptosis, AgNOR counts appear to
be a measure of some aspects of the proliferative activity. The
combination ofthese two parameters emerged as a strong discrim-
inator regarding treatment failures in non-metastatic glottic
carcinomas. Thus, strategies combining assessment of tumour
proliferation and apoposis-related proteins may prove to be fruitful
in the search for new prognostic tumour markers in squanmous cell
carcinomas of the head and neck.
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